115 related articles for article (PubMed ID: 26664641)
1. Two strategies for the synthesis of the biologically important ATP analogue ApppI, at a multi-milligram scale.
Weisell J; Vepsäläinen J; Turhanen PA
Beilstein J Org Chem; 2015; 11():2189-93. PubMed ID: 26664641
[TBL] [Abstract][Full Text] [Related]
2. Semi-preparative high-performance countercurrent chromatography method for the purification of chemically synthesized ATP analogue, ApppI.
Puljula E; Turhanen PA
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():180-182. PubMed ID: 28869872
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of the biologically important dideuterium-labelled adenosine triphosphate analogue ApppI(
Turhanen PA
Beilstein J Org Chem; 2022; 18():1466-1470. PubMed ID: 36300010
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a Biologically Important Adenosine Triphosphate Analogue, ApppD.
Turhanen PA
ACS Omega; 2017 Jun; 2(6):2835-2838. PubMed ID: 30023676
[TBL] [Abstract][Full Text] [Related]
5. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.
Jauhiainen M; Mönkkönen H; Räikkönen J; Mönkkönen J; Auriola S
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2967-75. PubMed ID: 19665949
[TBL] [Abstract][Full Text] [Related]
6. Selective Calcium-Dependent Inhibition of ATP-Gated P2X3 Receptors by Bisphosphonate-Induced Endogenous ATP Analog ApppI.
Ishchenko Y; Shakirzyanova A; Giniatullina R; Skorinkin A; Bart G; Turhanen P; Määttä JA; Mönkkönen J; Giniatullin R
J Pharmacol Exp Ther; 2017 Jun; 361(3):472-481. PubMed ID: 28404687
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
[TBL] [Abstract][Full Text] [Related]
8. Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.
Vantourout P; Mookerjee-Basu J; Rolland C; Pont F; Martin H; Davrinche C; Martinez LO; Perret B; Collet X; Périgaud C; Peyrottes S; Champagne E
J Immunol; 2009 Sep; 183(6):3848-57. PubMed ID: 19710470
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells.
Arkko S; Zlatev HP; Mönkkönen H; Räikkönen J; Benzaïd I; Clézardin P; Mönkkönen J; Määttä JA
Cancer Lett; 2015 Feb; 357(1):279-285. PubMed ID: 25444923
[TBL] [Abstract][Full Text] [Related]
10. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
Mitrofan LM; Pelkonen J; Mönkkönen J
Bone; 2009 Dec; 45(6):1153-60. PubMed ID: 19699819
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid-induced IPP/ApppI production in vivo.
Mönkkönen H; Ottewell PD; Kuokkanen J; Mönkkönen J; Auriola S; Holen I
Life Sci; 2007 Sep; 81(13):1066-70. PubMed ID: 17850825
[TBL] [Abstract][Full Text] [Related]
12. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Räikkönen J; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Pharmacol; 2010 Mar; 79(5):777-83. PubMed ID: 19819230
[TBL] [Abstract][Full Text] [Related]
13. Uptake of free, calcium-bound and liposomal encapsulated nitrogen containing bisphosphonates by breast cancer cells.
Zlatev HP; Auriola S; Mönkkönen J; Määttä JA
Eur J Pharm Sci; 2016 Apr; 86():58-66. PubMed ID: 26957415
[TBL] [Abstract][Full Text] [Related]
14. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of bisphosphonate activity: a preclinical perspective.
Green J; Clézardin P
Semin Oncol; 2010 Jun; 37 Suppl 1():S3-11. PubMed ID: 20682369
[TBL] [Abstract][Full Text] [Related]
16. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
Räikkönen J; Taskinen M; Dunford JE; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Biophys Res Commun; 2011 Apr; 407(4):663-7. PubMed ID: 21420384
[TBL] [Abstract][Full Text] [Related]
17. F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells.
Mookerjee-Basu J; Vantourout P; Martinez LO; Perret B; Collet X; Périgaud C; Peyrottes S; Champagne E
J Immunol; 2010 Jun; 184(12):6920-8. PubMed ID: 20483757
[TBL] [Abstract][Full Text] [Related]
18. N9-Substituted N⁶-[(3-methylbut-2-en-1-yl)amino]purine derivatives and their biological activity in selected cytokinin bioassays.
Mik V; Szüčová L; Spíchal L; Plíhal O; Nisler J; Zahajská L; Doležal K; Strnad M
Bioorg Med Chem; 2011 Dec; 19(23):7244-51. PubMed ID: 22019467
[TBL] [Abstract][Full Text] [Related]
19. Effect of an adenosine A(1) receptor agonist and a novel pyrimidoindole on membrane properties and neurotransmitter release in rat cortical and hippocampal neurons.
Eschke D; Brand A; Scheibler P; Hess S; Eger K; Allgaier C; Nieber K
Neurochem Int; 2001 Apr; 38(5):391-8. PubMed ID: 11222919
[TBL] [Abstract][Full Text] [Related]
20. Phenolic metabolites from Hypericum kelleri Bald., an endemic species of Crete (Greece).
Mathioudaki A; Berzesta A; Kypriotakis Z; Skaltsa H; Heilmann J
Phytochemistry; 2018 Feb; 146():1-7. PubMed ID: 29190454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
